Overview
Effects of Citalopram on Hostility and CHD Risk
Status:
Completed
Completed
Trial end date:
2003-02-01
2003-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To evaluate the therapeutic effects of the serotonergic agent, citalopram, on hostility and other behavioral risk factors, and biological markers of disease risk (serum lipids, insulin and glucose; autonomic balance and stress-related cardiovascular reactivity; platelet activation).Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of PittsburghCollaborator:
National Heart, Lung, and Blood Institute (NHLBI)Treatments:
CitalopramDexetimide